NeoGenomics, Inc.

NASDAQ:NEO

16.83 (USD) • At close December 27, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000
Revenue 591.643509.728484.329444.448408.83276.741258.611244.08399.80287.06966.46759.86743.48434.37129.46920.01511.5056.4761.8850.5580.370.0930.0010.252
Cost of Revenue 347.039321.832297.269258.555211.994149.476138.295133.70456.04646.35534.7333.03124.05618.58814.2549.3545.5232.7591.1880.5770.4820.1900.074
Gross Profit 244.604187.896187.06185.893196.836127.265120.316110.37943.75640.71431.73726.83619.42815.78315.21510.6615.9823.7170.697-0.019-0.112-0.0960.0010.178
Gross Profit Ratio 0.4130.3690.3860.4180.4810.460.4650.4520.4380.4680.4770.4480.4470.4590.5160.5330.520.5740.37-0.034-0.302-1.03210.706
Reseach & Development Expenses 27.30930.32621.8738.2298.4873.0013.6364.6494.1982.6892.442.2810000000000.04600
General & Administrative Expenses 243.101243.356221.347143.794127.99384.82288.75575.78233.63123.80817.39715.84312.87411.26710.057003.5771.4970.7110.3830.44100
Selling & Marketing Expenses 70.84267.32162.59447.86247.3529.40224.54323.9111.56211.9998.7267.5016.9637.4796.885000000000
SG&A 313.943310.677283.941191.656175.343114.224113.29899.69245.19335.80726.12323.34419.83718.74616.94211.5459.1233.5771.4970.7110.3830.4418.0791.123
Other Expenses 11.088-0.213-0.49911.861-4.630.014-1.3233.4642000000000000000.026
Operating Expenses 341.252341.003305.814199.885183.83117.225116.934104.34149.39138.49628.56325.62519.83718.74616.94211.5459.1233.5771.4970.7110.3830.4878.0791.149
Operating Income -107.736-153.107-9.993-2.1318.37610.043.3822.574-5.6352.2183.1741.211-0.409-2.963-1.728-0.884-3.1410.14-0.8-0.73-0.494-0.584-8.078-0.971
Operating Income Ratio -0.182-0.3-0.021-0.0050.020.0360.0130.011-0.0560.0250.0480.02-0.009-0.086-0.059-0.044-0.2730.022-0.425-1.307-1.336-6.243-8,077.966-3.847
Total Other Income Expenses Net 10.639-1.719103.679-0.064-9.361-6.216-5.552-9.9981.146-0.929-0.989-1.146-0.768-0.34-0.515-0.499-0.239-0.14-0.197-0.0890000.001
Income Before Tax -97.097-159.342-15.075-14.0563.6453.824-3.481-7.424-4.4891.2892.1850.065-0.003-2.593-1.71-1.074-3.1170.1400000-0.97
Income Before Tax Ratio -0.164-0.313-0.031-0.0320.0090.014-0.013-0.03-0.0450.0150.0330.001-0-0.075-0.058-0.054-0.2710.02200000-3.844
Income Tax Expense -9.129-15.092-6.728-18.228-4.3611.184-2.635-1.701-1.9540.1570.1521.1460.768-0.74-0.0340.180.215-0.1120.1970.0890.0410.2140-0.001
Net Income -87.968-144.25-8.3474.1728.0062.64-0.846-5.723-2.5351.1322.0330.065-1.177-3.303-2.243-1.383-3.38-0.13-0.997-0.819-0.536-0.591-8.078-0.97
Net Income Ratio -0.149-0.283-0.0170.0090.020.01-0.003-0.023-0.0250.0130.0310.001-0.027-0.096-0.076-0.069-0.294-0.02-0.529-1.468-1.448-6.316-8,077.966-3.844
EPS -0.7-1.16-0.070.0380.080.029-0.011-0.074-0.0420.020.040.001-0.028-0.089-0.065-0.044-0.11-0.005-0.045-0.041-0.037-0.14-2.14-1.24
EPS Diluted -0.7-1.16-0.070.0370.0770.029-0.011-0.074-0.0420.020.040.001-0.028-0.089-0.065-0.044-0.11-0.005-0.045-0.041-0.037-0.14-2.14-1.24
EBITDA -17.607-78.63152.07534.85243.26431.78626.55129.2473.5077.8587.5865.0291.676-0.812-0.526-0.143-2.6350.447-0.619-0.625-0.446-0.584-7.832-0.945
EBITDA Ratio -0.03-0.1650.090.0760.0950.1150.0950.120.0350.0250.0480.0840.039-0.045-0.019-0.008-0.2310.06-0.328-1.12-1.206-6.243-7,832.295-3.745